Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/02/2856469/0/en/Vaxcyte-to-Present-at-the-23rd-Annual-Needham-Virtual-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2024/03/04/2839584/0/en/Vaxcyte-Completes-Enrollment-of-Phase-2-Study-Evaluating-VAX-24-for-the-Prevention-of-Invasive-Pneumococcal-Disease-IPD-in-Infants.html
https://www.globenewswire.com//news-release/2024/02/27/2836415/0/en/Vaxcyte-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2024/02/15/2830367/0/en/Vaxcyte-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results-on-February-27-2024.html
https://www.globenewswire.com//news-release/2024/02/02/2823089/0/en/Vaxcyte-Announces-Closing-of-862-5-Million-Public-Offering-Including-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html
https://www.globenewswire.com//news-release/2024/02/01/2822450/0/en/Vaxcyte-to-Present-at-the-Guggenheim-Healthcare-Talks-6th-Annual-Biotechnology-Conference.html
https://www.globenewswire.com/news-release/2024/01/31/2820695/0/en/Vaxcyte-Announces-Pricing-of-750-Million-Public-Offering.html
https://www.globenewswire.com/news-release/2024/01/30/2820492/0/en/Vaxcyte-Announces-Commencement-of-Proposed-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html
https://investors.vaxcyte.com/news-releases/news-release-details/vaxcyte-completes-enrollment-phase-12-study-evaluating-vax-31
https://www.globenewswire.com//news-release/2024/01/16/2810301/0/en/Vaxcyte-Appoints-Whitney-Jones-as-Chief-People-Officer.html